2003
DOI: 10.1590/s0066-782x2003001100011
|View full text |Cite
|
Sign up to set email alerts
|

Ligation of the thoracic duct for the treatment of chylothorax in heart diseases

Abstract: If conservative treatment is not effective, surgical treatment should be considered 8 . Studies indicate that ligation of the thoracic duct and pleurodesis are efficient alternatives for resolution of chylothorax 9 .Recently, thoracic duct ligation through video-assisted thoracic surgery has been used in patients who did not respond to conservative treatment. Kirby et al 11 describe this conduct as less painful and with fewer postoperative complications.Pereira et al 12 describe the use of lymphatic ligation f… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
8
0

Year Published

2004
2004
2019
2019

Publication Types

Select...
6
1
1

Relationship

0
8

Authors

Journals

citations
Cited by 11 publications
(8 citation statements)
references
References 17 publications
(27 reference statements)
0
8
0
Order By: Relevance
“…(4,(6)(7)(8)(9) Various surgical techniques have been employed, such as pleurodesis with pleural abrasion (or with pleurectomy), pleuroperitoneal shunt, shunt between the pleural cavity and the subclavian vein, anastomosis between the thoracic duct and the azygos vein, and thoracic duct ligation, the last being the most commonly performed. (4,8,(12)(13)(14)(15) The thoracic duct ligation technique has two variants. Mass ligature of the thoracic duct is performed without the individual dissection of the thoracic duct, and all of the tissue of the aorta, thoracic spine, esophagus, and azygos vein is mass ligated.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…(4,(6)(7)(8)(9) Various surgical techniques have been employed, such as pleurodesis with pleural abrasion (or with pleurectomy), pleuroperitoneal shunt, shunt between the pleural cavity and the subclavian vein, anastomosis between the thoracic duct and the azygos vein, and thoracic duct ligation, the last being the most commonly performed. (4,8,(12)(13)(14)(15) The thoracic duct ligation technique has two variants. Mass ligature of the thoracic duct is performed without the individual dissection of the thoracic duct, and all of the tissue of the aorta, thoracic spine, esophagus, and azygos vein is mass ligated.…”
Section: Discussionmentioning
confidence: 99%
“…However, in most studies, surgical interventions are recommended when there is no resolution after 1-3 weeks of clinical treatment, or if the daily drainage exceeds 100 mL/kg. (4,8,(12)(13)(14)(15) Thoracic duct ligation, performed for the first time by Lampson in 1948, (16) is an efficient treatment option for patients with low morbidity. The use of videoassisted techniques has recently been described.…”
mentioning
confidence: 99%
“…(8) Postoperative chylothorax is an uncommon situation which can manifest at up to four weeks after the initial procedure, presenting an significant risk of mortality, which can reach 50%. (11,12) The consequences include possible impairment (mechanical, immunological and metabolic). (8,12) The quantity of lymphatic fluid accumulated in one hemithorax can cause the compression of in recommending surgery could lead to unnecessary nutritional and immunological depletion.…”
Section: Discussionmentioning
confidence: 99%
“…Some other studies reported using pleurodesis, pleurectomy, low ligation of the thoracic duct by video-assisted thoracoscopic surgery, thoracic duct embolisation, and pericardial-peritoneal shunting. 11,[21][22][23] Few reports have been published on the off-label use of the long-acting somatostatin analog, octreotide, that is presumed to cause a reduction in chyle production and thoracic duct flow rate. [24][25][26][27] The use of non-steroidal anti-inflammatory drugs has been the cornerstone in the treatment of patients with pericarditis, but no studies were published on its use in chylopericardium.…”
mentioning
confidence: 99%